Atlas Trials

A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).

Clinical trial NCT07081178 · TERMINATED

Trial details

NCT number
NCT07081178
Sponsor
Novo Nordisk A/S
Status
TERMINATED
Study type
OBSERVATIONAL
Obesity
Start date
2025-08-08
Primary completion
2025-12-18
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.